Constantijn specializes in corporate advisory. His primary focus is corporate law, including governance, advisory and mergers and acquisitions.
Constantijn regularly advises founder-led businesses and family-owned corporations, both listed and privately held, on their corporate structure and founder / family corporate governance.
Constantijn has extensive experience across the field of corporate law. A substantial part of his practice is cross-border, reflecting his experience in international transactions involving IPOs, corporate restructurings, joint ventures, and strategic deals.
Constantijn practised law at De Brauw London, where he advised large international companies and financial institutions on corporate and finance transactions involving multiple jurisdictions. 
Constantijn’s recent work includes advising:
<ul><li>CTP on its listing on Euronext</li><li>the underwriters on the IPO of CureVac on NASDAQ</li><li>CM.com on its listing on Euronext through a business combination with Dutch Star Companies One</li><li>the Dutch State on the launch of Invest-NL</li><li>IGEA on its listing on SIX Swiss exchange</li><li>Pre-IPO corporate structuring of a major software-as-a-service platform</li><li>Vitol on its joint venture with Sargeant Marine </li><li>Avast on the acquisition of AVG</li><li>Various state-owned companies on their governance and corporate structuring </li><li>Various founder-led and family-owned companies on transactions and structuring</li></ul>

Constantijn voogt

Constantijn Voogt

Partner

Jan Willem specialises in international corporate finance with a focus on cross-border equity capital markets transactions. He advises corporates and financial institutions close to home and far afield. His regulatory practice ranges from buy-back programmes to cross-border clearing and settlement, and from block trades to insider trading issues.
For over a decade, Chambers and Legal 500 have consistently ranked Jan Willem in Tier 1 for equity capital markets, with Legal 500 welcoming him into their Equity Capital Markets Hall of Fame for the Netherlands. Clients describe him as “thorough, hands-on and practical.” Sources add: “He really digs into the detail and is likeable and easy to communicate with.” 
Jan Willem’s work includes advising
<ul><li>FrieslandCampina on the restructuring of its member financing</li><li>Van Lanschot Kempen on the simplification of its group structure</li><li>Royal Philips on the dual track IPO/M&amp;A process for its domestic appliances business </li><li>Stellantis on its listing in relation to the EUR 50 billion merger between Fiat Chrysler and Peugeot</li><li>Fugro on its EUR 250 million rights offering and the abolition of its depositary receipts </li><li>the underwriters on the aborted 3.5 billion Unibail-Rodamco rights offering</li><li>CM.com on its listing on Euronext Amsterdam through a business combination with a SPAC</li><li>Takeaway.com on the capital market aspects of its merger with Just Eat, including its listing on the LSE</li><li>Topicus and its founders on their strategic direction leading to a business combination and listing in Canada</li><li>on the dual track process and ultimate IPO of Philips Lighting</li><li>LeasePlan on its proposed IPO</li><li>ABN AMRO Group on its IPO</li><li>Royal BAM Group on its convertible bond</li><li>IMCD on its IPO and subsequent ABB offerings</li><li>Prosensa on its listing on Nasdaq and its subsequent take-private</li><li>Organon BioSciences on its proposed IPO</li></ul>

Janwillem hoevers

Jan Willem Hoevers

Reinier advises on public and private mergers and acquisitions, corporate governance and general corporate matters. He is the trusted adviser to various of listed companies and large multinationals on corporate governance matters, anti-takeover responses (including relating to shareholder activism) and various legal and practical aspects of their listing. His M&amp;A practice has a particular focus on (public) cross-border transactions.

Reinier kleipool

Reinier Kleipool

Féline is counsel in De Brauw’s Corporate practice, with a specific focus on cross-border Equity Capital Markets and Mergers and Acquisitions.
Féline's practice includes advising on private M&amp;A transactions and on all aspects of securities offerings and listings, including prospectus requirements and cross-border clearing and settlement structures. She also assists corporates in their compliance with financial reporting obligations and financial market regulations, including market abuse, ongoing obligations, insider trading issues and stock exchange rules. 
Féline was seconded to a large national bank in 2015/2016 and to the corporate department of the New York law firm, Davis Polk &amp; Wardwell LLP, from September 2022 through August 2023.
Féline's recent work includes advising:
<ul><li>Royal Philips on the dual track for its Domestic Appliances business</li><li>Hapag-Lloyd on its acquisition of NileDutch </li><li>Beter Bed on the divestment of its DACH business, Matratzen Concord </li><li>TechnipFMC on the spin-off and listing of Technip Energies N.V. on Euronext France </li><li>The underwriters on the IPO of LAVA Therapeutics on Nasdaq </li><li>The underwriters on the IPO of Mytheresa B.V. on NYSE </li><li>CM.com on its Euronext listing through a business combination with a SPAC </li><li>Affimed on various capital raises and related securities work </li><li>Unilever and other N.V.'s on US/Europe/Amsterdam cross settlement </li><li>A sophisticated retail business with highly developed omni-channel sales, influencer and return platform on its IPO (aborted in last phase) </li><li>Takeaway.com on its IPO on Euronext Amsterdam </li><li>ABN AMRO on its IPO on Euronext Amsterdam </li><li>Royal Ahold Delhaize on its proposed sub-IPO of bol.com </li><li>Fugro on its rights issue and convertible bond offerings </li><li>EPIC Acquisition Corp, a SPAC, on its EUR 150 million offering and listing on Euronext Amsterdam</li></ul>

Feline goyarts

Féline Goyarts

Counsel

De Brauw Blackstone Westbroek advised Affimed on its IPO on the NASDAQ Global Market. Affimed will offer a total of 9,200,000 shares, with the deal pricing on 12 September 2014 at USD 7,00 per share. 
Affimed is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. 
De Brauw acted as Dutch counsel to Affimed and Constantijn Voogt was lead partner.

Capital 
Markets

Mergers & 
Acquisitions

Home

Matter overview

IPO Affimed on NASDAQ

Breadcrumbs

De Brauw is widely recognised as a leading international law firm in the Netherlands. For nearly 150 years, we have been standing by our clients as a strong and spirited collective of leading legal experts. Through profound engagement with the business of our clients and a deep understanding of their ambitions, we build relationships of trust - some of which already stand for more than one hundred years.

De Brauw Blackstone Westbroek

De Brauw Blackstone Westbroek advised Affimed on its IPO on the NASDAQ Global Market. Affimed will offer a total of 9,200,000 shares, with the deal pricing on 12 September 2014 at USD 7,00 per share.   Affimed is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. De Brauw acted as Dutch counsel to Affimed and Constantijn Voogt was lead partner.

De Brauw Blackstone Westbroek advised Affimed on its IPO on the NASDAQ Global Market. Affimed will offer a total of 9,200,000 shares, with the deal…

description

generator

law firm,lawyer,legal,legal firm,amsterdam,international law firm

keywords

https://dwbxnuhxoazve.cloudfront.net/Icons/_1200x630_crop_center-center_82_none/og_image.png?mtime=1710424428

https://www.linkedin.com/company/de-brauw-blackstone-westbroek/

https://www.facebook.com/careersatdebrauw

https://www.debrauw.com/matters/ipo-affimed-on-nasdaq

referrer

robots

twitter:card

twitter:creator

twitter:description

https://dwbxnuhxoazve.cloudfront.net/Icons/_800x418_crop_center-center_82_none/og_image.png?mtime=1710424428

Areas of expertise

Sector

Topic

Areas of expertise

Sector

Topic

IPO Affimed on NASDAQ

Team

Constantijn Voogt

Jan Willem Hoevers

Reinier Kleipool

Féline Goyarts

Offices

Contact

Subscribe